Spaulding-Harvard TBI Model System (SH-TBIMS) is one of 16 centers in the nation that have been selected by the National Institute of Disability and Rehabilitation Research (NIDRR) to receive federal funding as a Traumatic Brain Injury Model System (TBIMS) for the 2012-2017 funding cycle. The SH-TBIMS is comprised of Massachusetts General Hospital (MGH) and Brigham and Women’s Hospital (BWH), our two Level 1 trauma centers, and Spaulding Rehabilitation Hospital (SRH) and Spaulding Hospital Cambridge (SHC), our two inpatient rehabilitation sites.
As a TBI Model System, Spaulding is a national leader in TBI research and care. Spaulding has worked hard to improve care for patients with severe acquired brain injury, including the development of the Disorders of Consciousness (DoC) program, which tailors care to each patient's individual needs. As a Model System, Spaulding-Harvard works to continuously be on the cutting-edge of TBI research.
As Lead Center
|Title||Type||Start Date||End Date|
|Development, validation and feasibility of the Coma Recovery Scale- Revised for Accelerated Standardized Testing (CRSR-FAST)||09/30/2017||09/29/2022|
|Partnering with Caregivers to Increase Knowledge of the Post-Acute Phase of Recovery from Severe TBI: Development and validation of the "Post-Acute Survey on Severe Disability after TBI (PASSD-TBI)"||Modular (Joint)||09/30/2017||09/29/2022|
|Functional Outcome Measure Module Project||07/01/2013||09/30/2013|
|Looking for Consciousness: A Novel Functional Neuroimaging Approach for Detection of Visual Cognition in Patients with Severe TBI and Disorders of Consciousness||Independent||10/01/2012||09/30/2017|
As Participating Center
|Development and Assessment of Crosswalks in the TBIMS Database||Modular (Joint)||01/01/2018||10/01/2019|
|Trajectories of Cognitive Functioning Years after TBI (BTACT)||Modular (Joint)||10/01/2017||09/30/2022|
|Understanding Causes of Death within the TBI Model Systems (Verbal Autopsy)||Collaborative||09/30/2012||10/01/2017|
|Brief Test of Adult Cognition by Telephone (BTACT)||Collaborative||09/30/2012||10/01/2017|
|Double-Blind, Placebo-controlled Trial of Amantadine Hydrochloride in the Treatment of Chronic TBI Irritability and Aggression: A Replication Study||Collaborative||09/01/2007||08/31/2012|